[PDF][PDF] Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals
Understanding adaptive immunity to SARS-CoV-2 is important for vaccine development,
interpreting coronavirus disease 2019 (COVID-19) pathogenesis, and calibration of pandemic …
interpreting coronavirus disease 2019 (COVID-19) pathogenesis, and calibration of pandemic …
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
INTRODUCTION Immunological memory is the basis for durable protective immunity after
infections or vaccinations. Duration of immunological memory after severe acute respiratory …
infections or vaccinations. Duration of immunological memory after severe acute respiratory …
[PDF][PDF] Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity
Limited knowledge is available on the relationship between antigen-specific immune
responses and COVID-19 disease severity. We completed a combined examination of all three …
responses and COVID-19 disease severity. We completed a combined examination of all three …
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
…, ED Yu, R da Silva Antunes, J Greenbaum, A Frazier… - Science, 2020 - science.org
Many unknowns exist about human immune responses to the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) virus. SARS-CoV-2–reactive CD4 + T cells have been …
syndrome coronavirus 2 (SARS-CoV-2) virus. SARS-CoV-2–reactive CD4 + T cells have been …
[PDF][PDF] Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals
…, P Rubiro, A Sutherland, E Wang, A Frazier… - Cell Reports …, 2021 - cell.com
The emergence of SARS-CoV-2 variants with evidence of antibody escape highlight the
importance of addressing whether the total CD4 + and CD8 + T cell recognition is also affected. …
importance of addressing whether the total CD4 + and CD8 + T cell recognition is also affected. …
[PDF][PDF] Humoral and cellular immune memory to four COVID-19 vaccines
Multiple COVID-19 vaccines, representing diverse vaccine platforms, successfully protect
against symptomatic COVID-19 cases and deaths. Head-to-head comparisons of T cell, B cell, …
against symptomatic COVID-19 cases and deaths. Head-to-head comparisons of T cell, B cell, …
[PDF][PDF] Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases
…, P Rubiro, N Methot, E Phillips, S Mallal, A Frazier… - Cell Reports …, 2021 - cell.com
T cells are involved in control of SARS-CoV-2 infection. To establish the patterns of
immunodominance of different SARS-CoV-2 antigens and precisely measure virus-specific CD4 + …
immunodominance of different SARS-CoV-2 antigens and precisely measure virus-specific CD4 + …
T cells from patients with Parkinson's disease recognize α-synuclein peptides
Genetic studies have shown the association of Parkinson’s disease with alleles of the major
histocompatibility complex 1 , 2 , 3 . Here we show that a defined set of peptides that are …
histocompatibility complex 1 , 2 , 3 . Here we show that a defined set of peptides that are …
[HTML][HTML] α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson's disease
A diagnosis of motor Parkinson’s disease (PD) is preceded by a prolonged premotor phase
with accumulating neuronal damage. Here we examined the temporal relation between α-…
with accumulating neuronal damage. Here we examined the temporal relation between α-…
Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function
…, J Hagen, V Tompkins, AA Frazier… - … and cellular biology, 2005 - Taylor & Francis
The ARF tumor suppressor is a nucleolar protein that activates p53-dependent checkpoints
by binding Mdm2, a p53 antagonist. Despite persuasive evidence that ARF can bind and …
by binding Mdm2, a p53 antagonist. Despite persuasive evidence that ARF can bind and …